Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents

Add time:07/13/2019    Source:sciencedirect.com

Structural based molecular docking approach revealed the findings of 2-(phenoxymethyl) -5-phenyl-1,3,4-oxadiazole derivatives. The compounds (7a-o) were synthesized and characterized well by using conventional methods. The compounds, 7b and 7m were reconfirmed through single crystal XRD analysis. The synthesized compounds (7a-o) were evaluated their antiproliferative activities against MCF-7 and MDA-MB-453. Furthermore, Lipinski's rule of five and pharmacokinetic properties were predicted for the test compounds. These results demonstrate that the compounds 7b and 7d exhibit more potent cytotoxicity and 7d exhibits dose-dependent activity and reduced cell viability. Further, the mechanism of action for the induced apoptosis was observed through morphological changes and western blotting analysis. These findings may furnish the lead for further development.

We also recommend Trading Suppliers and Manufacturers of 2-(phenoxymethyl)-1,3-benzoxazole (cas 7506-48-1). Pls Click Website Link as below: cas 7506-48-1 suppliers

Prev:New phenoxymethyl substituted mesoionic triazolium salts: Synthesis and structural characterisation
Next:Synthesis and in vitro antitumour evaluation of benzothiazole-2-carbonitrile derivatives)